I last reviewed West Pharmaceutical (WST) in this April 29 post at which time I disclosed my intent to purchase an additional 50 shares in a 'Core' account within the FFJ Portfolio; I did acquire another 50 shares on April 29 @ ~$357.54 thereby bringing my exposure to 200 shares. Not much has changed since [...]
The Canadian Federal government's 2024 Budget proposes to: increase the capital gains inclusion rate for capital gains realized on and after June 25, 2024, from 50% to 66.67% for corporations and trusts; and from 50% to 66.67% on the portion of capital gains realized in the year that exceed $250,000 for individuals. This change in [...]
The purpose of this brief post is to disclose that I have exited Bank of Montreal, Scotiabank, and CIBC which are Canada's 3rd, 4th, and 5th largest banks from a market capitalization perspective. The Canadian Federal government's 2024 Budget proposes to increase the capital gains inclusion rate for capital gains realized on and after June [...]
The Canadian Federal government in its infinite wisdom has introduced its 2024 Budget. The Budget calls for an increase of the inclusion rate on capital gains realized annually above $250,000 by individuals and on all capital gains realized by corporations and trusts from one-half to two-thirds. The amendments to the Income Tax Act are to [...]
My analysis of Union Pacific is accessible through my guest post at Dividend Power. Class I railroads (UNP is one of 6) are generally a bellwether of economic growth and they are generally good at forecasting how different industrial sectors are likely to perform. This is because they receive input from their customers who need [...]
I became a Becton Dickinson shareholder in February 2009. For the first several years of ownership, BDX's financial performance was fine. The addition of Carefusion in 2015 worked out fine but following the C.R. Bard acquisition in December 2017, things started to go downhill. The spin off of its Diabetes Care business into a newly [...]
Once upon a time, BCE Inc. (BCE) was the quintessential 'widows and orphans' stock. Investors seeking income could count on BCE to distribute its quarterly dividend like clockwork. Now? BCE is a 'dog with fleas'. I can't specifically pinpoint when I became a BCE shareholder but I know my parents acquired BCE shares for me [...]
I last reviewed Paycom Software (PAYC) in my February 8, 2024 post following the release of Q4 and FY2023 results. With the release of Q1 2024 results on May 1, 2024 I revisit this existing holding. Business Overview I have provided a brief business overview in prior posts. The best sources of information to learn [...]
This FFJ Portfolio - April 2024 report recaps my investment activity during the month of April. A snapshot of the holdings within the portfolio at the end of each month from December 2018 to March 2024 is accessible here. In December 2018, the FFJ Portfolio totals were: Core Accounts: ~$350,809 CDN and ~$418,907 USD Side [...]
I last reviewed Copart (CPRT) in this November 17, 2023 post at which time the most current financial information was for Q1 2024. Following that post, I disclosed in my January 2024 FFJ Portfolio report the purchase of CPRT shares for two young investors I am helping on their journey to financial freedom; I [...]